Atlas Trials

Bendamustine and Rituximab Combination Therapy for Cold Agglutinin Disease

Clinical trial NCT02689986 · COMPLETED

Trial details

NCT number
NCT02689986
Sponsor
Helse Fonna
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cold Agglutinin DiseaseAutoimmune Hemolytic Anemia
Start date
2013-01-01
Primary completion
2016-12-01
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.